Ocular Therapeutix
Trade Ocular Therapeutix 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About OCUL
Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC.
OCUL Key Statistics
Stock Snapshot
With a market cap of 2.1B, Ocular Therapeutix(OCUL) trades at $9.28. The stock has a price-to-earnings ratio of -6.50.
On 2026-08-09, Ocular Therapeutix(OCUL) stock moved within a range of $8.80 to $9.28. With shares now at $9.28, the stock is trading +5.5% above its intraday low and 0.0% below the session's peak.
Trading volume for Ocular Therapeutix(OCUL) stock has reached 2.01M, versus its average volume of 2.13M.
The stock's 52-week range extends from a low of $6.23 to a high of $16.44.
The stock's 52-week range extends from a low of $6.23 to a high of $16.44.
OCUL News
In early August 2026, Ocular Therapeutix reported second-quarter 2026 results showing revenue of US$13.48 million, essentially flat year on year, while net loss...
Reports Q2 revenue $13.48M, consensus $13.2M. “We continue to execute with discipline, precision, and urgency to redefine the retina experience and make AXPAXLI...
Analyst ratings
100%
of 12 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.